Analysis of mouse brain peptides using mass spectrometry-based peptidomics: implications for novel functions ranging from non-classical neuropeptides to microproteins.
Peptides are known to play many important physiological roles in signaling. A large number of peptides have been detected in mouse brain extracts using mass spectrometry-based peptidomics studies, and 850 peptides have been identified. Half of these peptides are derived from secretory pathway proteins and many are known bioactive neuropeptides which activate G protein-coupled receptors; these are termed "classical neuropeptides". In addition, 427 peptides were identified that are derived from non-secretory pathway proteins; the majority are cystosolic, and the remainder are mitochondrial, nuclear, lysosomal, or membrane proteins. Many of these peptides represent the N- or C-terminus of the protein, rather than internal fragments, raising the possibility that they are formed by selective processing rather than protein degradation. In addition to consideration of the cleavage site required to generate the intracellular peptides, their potential functions are discussed. Several of the cytosolic peptides were previously found to interact with receptors and/or otherwise influence cellular activity; examples include hemorphins, hemopressins, diazepam binding inhibitor, and hippocampal cholinergic neurostimulating peptide. The possibility that these peptides are secreted from cells and function in cell-cell signaling is discussed. If these intracellular peptides can be shown to be secreted in levels sufficient to produce a biological effect, they would appropriately be called "non-classical neuropeptides" by analogy with non-classical neurotransmitters such as nitric oxide and anandamide. It is also possible that intracellular peptides function as "microproteins" and modulate protein-protein interactions; evidence for this function is discussed, along with future directions that are needed to establish this and other possible functions for peptides.
Fricker
Lloyd D
LD
Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA. lloyd.fricker@einstein.yu.edu
D000818:Animals; D013058:Mass Spectrometry / Q000379:methods*; D051379:Mice; D008954:Models, Biological; D008970:Molecular Weight; D009479:Neuropeptides / Q000032:analysis* / Q000737:chemistry / Q000502:physiology*; D011506:Proteins / Q000737:chemistry / Q000502:physiology*; D040901:Proteomics / Q000379:methods*; D055571:Secretory Pathway / Q000502:physiology
D009479:Neuropeptides; D011506:Proteins